Fluorescent in situ hybridization study of c-myc oncogene copy number in prostate cancer

Experimental and Molecular Pathology

Volumn 68, Issue 1, 2000, Pages 65-69

  Mark, Hon Fong L ^a   Samy, Mangala ^a   Santoro, Kathleen ^a   Mark, Seamus ^a   Feldman, David ^a  

^a KRAM Corporation   (United States)

Author keywords

c myc; Copy number; FISH; Fluorescent in situ hybridization; Oncogene; Prostate cancer

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; HUMAN; HUMAN TISSUE; MALE; ONCOGENE C MYC; ONCOGENE NEU; PROSTATE CANCER; QUALITY OF LIFE; TRISOMY 7; TRISOMY 8;

EID: 0033961413     PISSN: 00144800     EISSN: None     Source Type: Journal    
DOI: 10.1006/exmp.1999.2282     Document Type: Article

References (31)

1. Afify A., Bland K. I., Mark H. F. L. Fluorescent in situ hybridization assessment of chromosome 8 copy number in breast cancer. Breast Cancer Res. Treat. 38:1996;201-208
2. Afify A., Mark H. F. L. FISH assessment of chromosome 8 copy number in Stage I and Stage II infiltrating ductal carcinoma of the breast. Cancer Genet. Cytogenet. 97:1997;101-105
3. Afify A. M., Werness B. A., Mark H. F. L. HER-2/neuoncogene amplification in stage I and stage III ovarian papillary serous carcinoma. Exp. Mol. Pathol. 66:1999;163-169
4. Allred D. C., Clark G. M., Tandon A. K., Molina R., Tormey D. C., Osborne C. K., Gilchrist K. W., Mansour E. G., Abeloff M., Eudey L., McGuire W. L. HER-2/neu in node-negative breast cancer: Prognostic significance of overexpression influenced by the presence of in situ carcinoma. J. Clin. Oncol. 10:1992;599-605
5. Bland K. I. The molecular pathology of colorectal and mammary carcinoma: Prognostic and therapeutic implications for surgeons. Ann. Surg. 222:1995;II-VII
6. Bland K. I., Konstadoulaki M. M., Vezeridis M. P., Wanebo H. J. Oncogene protein co-expression: Value of Ha-ras, c-myc, c-fos, and p53 as prognostic discriminants for breast carcinoma. Ann. Surg. 221:1995;706-720
7. Carter H. B., Partin A. W. Diagnosis and staging of prostate cancer. Walsh P. C. Campbell's Urology, 7th ed. 1998;Saunders, Philadelphia
8. Clark G. M., Dressler L. G., Owens M. A., Pounds G., Oldaker T., McGuire W. L. Prediction of relapse or survival in patients with node-negative breast cancer by DNA flow cytometry. N. Engl. J. Med. 320:1989;627-633
9. Field J. K., Spandidos D. A. The role of ras and myconcogenes in human solid tumours and their relevance in diagnosis and prognosis (review). Anticancer Res. 10:1990;1-22
10. Fournier G., Latil A., Amet Y., Abalain J. H., Volant A., Mangin P., Floch H. H., Lidereau R. Gene amplification in advanced-stage human prostate cancer. Urol. Res. 22:1995;343-347
11. Gullick W. J., Love S. B., Wright C., Barnes D. M., Gusterson B., Harris A. L., Altman D. G. c-erB-2 protein overexpression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodes. Br. J. Cancer. 63:1991;434-438
12. Hedley D. W., Freidlander M., Taylor I., Rugg C., Musgrove E. Method for analysis of cellular DNA content of paraffin embedded pathological material using flow cytometry. J. Histochem. Cytochem. 31:1983;1331-1335
13. Jenkins R. B., Qian J., Lieber M. M., Bostwick D. G. Dectection of c-myc oncogene amplification and chromosomal anomolies in metastatic prostatic carcinoma by fluorescence in situ hybridization. Cancer Res. 57:1997;524-531
14. Latil A., Baron J. C., Cussenot O., Fournier G., Boccon-Gibod L., Le-Duc A., Lidereau R. Oncogene amplification in early-stage human prostate carcinomas. Int. J. Cancer. 59:1994;637-638
15. Mark H. F. L. Fluorescent in situ hybridization as an adjunct to conventional cytogenetics. Ann. Clin. Laboratory Science 24:1994;153-163
16. Mark H. F. L., Huth A., Santoro K., Ferreira K., Barker B. Sequential flow cytometry and FISH for the study of formalin-fixed paraffin-embedded breast cancer tissues. Cancer Genet. Cytogenet. 98:1997a;1-5
17. Mark H. F. L., Afify A., Taylor W., Santoro K., Lathrop J. A subset of gestational trophoblastic disease characterized by abnormal chromosome 8 copy number detected by fluorescence in situ hybridization. Cancer Genet. Cytogenet. 99:1997b;24-29
18. Mark H. F. L. Interphase cytogenetics for studying solid tumors. Invited Editorial. Cancer. 83:1998;839-843
19. Mark H. F. L., Brown S., Sun C.-L., Samy M., Afify A. Fluorescent in situ hybridization detection of HER-2/neu gene amplification in rhabdomyosarcoma. Pathobiology. 66:1998;59-63
20. Mark H. F. L., Aswad B., Bassily N., Taylor W., Brown S., Sun C.-L., Samy M., Zolnierz K., Wong E., Kim D., Bland K. I., Hsu P. H. HER-2/neu gene amplification in stages I-IV breast cancer detected by fluorescent in situ hybridization. Genet. Med. 1:1999a;98-103
21. Mark H. F. L., Feldman D., Das S., Kye H., Mark S., Sun C.-L., Samy M. Fluorescent in situ hybridization study of HER-2/neu oncogene amplification in prostate cancer. Exp. Mol. Pathol. 66:1999b;170-178
22. Mark H. F. L., Feldman D., Das S., Sun C.-L., Samy M., Brown S., Lathrop J. HER-2/neu oncogene amplification in cervical cancer studied by fluorescent in situ hybridization. Genet. Testing. 3:1999c;237-242
23. Mark H. F. L., Afify A. M., Werness B. A., Das S., Mark S., Samy M. Trisomy 8 in stage I and stage III ovarian cancer detected by fluorescent in situ hybridization. Exp. Mol. Pathol. 66:1999d;76-81
24. Mark, H. F. L., Feldman, D., Das, S., Samy, M., Sun, C.-L., and Mark, S. (1999e). Assessment of chromosomal trisomies in prostate cancer using fluorescent in situ hybridization.Exp. Mol. Pathol., in press
25. Nupponen N. N., Kakkola L., Koivisto P., Visakorpi T. Genetic alterations in hormone-refractory recurrent prostate carcinomas. Am. J. Pathol. 153:1998;141-148
26. Press M. F., Pike M. C., Chanzin V. R., Hung G., Udove J. A., Markowicz M., Danyluk J., Godolphin W., Sliwkowski M., Akita R., Paterson M. C., Slamon D. J. HER-2/neu expression in node-negative breast cancer: Direct tissue quantitation by computerized image analysis and association of overexpression with in creased risk of recurrent disease. Cancer Res. 53:1993;4960-4970
27. Qian J., Jenkins R. B., Bostwick D. G. Detection of chromosomal anomalies and c-myc gene amplification in the cribriform pattern of prostatic intraepithelial neoplasia and carcinoma by fluorescence in situ hybridization. Mod. Pathol. 10:1997;1113-1119
28. Sandberg A. A. The Chromosomes in Human Cancer and Leukemia. 1990;Elsevier, New York
29. Slamon D. J. Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science. 235:1987;177-182
30. Takahashi Y., Shintaku K., Ishii Y., Asai S., Ishikawa K., Fujii M. Analysis of MYC and chromosome 8 copy number changes in gastrointestinal cancers by dual-color fluorescence in situ hybridization. Cancer Genet. Cytogenet. 107:1998;61-64
31. Visscher D. W., Wallis T., Awussah S., Mohamed A., Crissman J. D. Evaluation of MYC and chromosome 8 copy number in breast carcinoma by interphase cytogenetics. Genes Chromosomes Cancer. 18:1997;1-7